Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Oct 14;22(10):1413-1414.
doi: 10.1093/neuonc/noaa187.

Integrated analysis of pediatric low-grade glioma: clinical implications and the path forward

Roger J Packer  1 , Tobey J MacDonald  2
Affiliations
Comment

Integrated analysis of pediatric low-grade glioma: clinical implications and the path forward

Roger J Packer et al. Neuro Oncol. .
No abstract available

PubMed Disclaimer

Comment on

  • Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.
    Fukuoka K, Mamatjan Y, Tatevossian R, Zapotocky M, Ryall S, Stucklin AG, Bennett J, Nobre LF, Arnoldo A, Luu B, Wen J, Zhu K, Leon A, Torti D, Pugh TJ, Hazrati LN, Laperriere N, Drake J, Rutka JT, Dirks P, Kulkarni AV, Taylor MD, Bartels U, Huang A, Zadeh G, Aldape K, Ramaswamy V, Bouffet E, Snuderl M, Ellison D, Hawkins C, Tabori U. Fukuoka K, et al. Neuro Oncol. 2020 Oct 14;22(10):1474-1483. doi: 10.1093/neuonc/noaa077. Neuro Oncol. 2020. PMID: 32242226 Free PMC article.

References

    1. Pfister S, Janzarik WG, Remke M, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008;118(5):1739–1749. - PMC - PubMed
    1. Packer RJ, Pfister S, Bouffet E, et al. Pediatric low-grade gliomas: implications of the biologic era. Neuro Oncol. 2017;19(6):750–761. - PMC - PubMed
    1. Jones DTW, Kieran MW, Bouffet E, et al. Pediatric low-grade gliomas: next biologically driven steps [published correction appears in Neuro Oncol. 2018 Jan 22;20(2):293]. Neuro Oncol. 2018;20(2):160–173. doi:10.1093/neuonc/nox141. PMID: 29016845. - PMC - PubMed
    1. Packer RJ, Iavarone A, Jones DTW, et al. Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference. Neuro Oncol. 2020;22(6):773–784. - PMC - PubMed
    1. Fangusaro J, Onar-Thomas A, Young Poussaint T, et al. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol. 2019;20(7):1011–1022. - PMC - PubMed